Advanced therapy companies have been rapidly populating over the past few years, making it a high-value, fast-growth market. Key drivers for the market include high rates of clinical trials, accelerated pathways for product approvals, new technologies to support cell and gene therapy manufacturing, and the potential for advanced therapies to revolutionize healthcare.
Stem Cell Industry Collaboration
Stem cell treatments in particular have gained more and more traction over the last decade. As of October 2019, stem cell scientific publications have reached over 364,930 worldwide, with 25,000+ now being published per year.
For stem cell clinical trials, more than 7,400 have been registered on ClinicalTrials.gov. Because this registry includes approximately 3/4ths of clinical trials worldwide, the total number of stem cell clinical trials worldwide is estimated to be nearly 10,000.
These historic events demonstrate to investors, the public and funding providers alike that the cell and gene therapy is a market that has emerged, no longer one that is evolving in the future.
With accelerating momentum fueling the industry, BioInformant is honored to be a partner for Phacilitate Leaders World in Miami, FL, on January 21-24. 2020.
What Is Phacilitate Leaders World?
While there are many exciting events each year, there are invariably a few that stand out from the crowd. Hosted each January in sunny Florida, Phacilitate Leaders World (PLW) will attract 1,600+ attendees across the world, making it the largest networking and partnering event to serve the Regenerative Medicine (RM) community.
As in past years, the event will showcase small and large companies, investors, and regulators, as well as facilitates strategic knowledge exchange. Focused on solutions to support R&D, accelerate clinical progress, and break through manufacturing bottlenecks, attendees will get to learn from key voices that are defining commercial success for cell and gene therapy products.
With 25+ hours of networking, 350+ organizations, and 200+ speakers from across the globe, the event provides extensive opportunities for collaboration and networking.
Below is a video featuring highlights from last year’s event and showcasing what you can expect from attending in 2020.
Co-Located with the World Stem Cell Summit
Through strong partnerships and collaboration, anything can be achieved. For this reason, Phacilitate Leaders World will again be co-located with the World Stem Cell Summit in 2020.
Over four days, attendees will attend seven concurrent tracks, as well as one-on-meetings and group networking events. One of the unique tracks hosted each year is the Cord Blood and Perinatal Stem Cell Track. Shared between the Phacilitate Leaders World and World Stem Cell Summit agendas, this track will provides insight on business models and financing opportunities, as well as scientific and technical updates on clinical applications and cell expansion approaches.
Endorsed by BioInformant and the Cord Blood Association (CBA), the Cord Blood & Perinatal Stem Cell track is a must-attend series for those invested in realizing the potential of this expanding sector.
10% Off with Code “BIOINFORMANT”
Because we would love to meet you in person, we have arranged for you to get 10% off of either your delegate pass or sponsorship package with the code “BIOINFORMANT.”
Use it during registration to lock in your free savings.
Phacilitate’s Cell & Gene Therapy World
January 22-25, 2020
Will you be attending this year’s event? If so, leave us a comment below, so we can meet up there!